These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 833253)

  • 41. [Insulin receptor antibodies].
    Ogawa W; Yokono K; Kasuga M
    Nihon Rinsho; 1991 Feb; 49 Suppl():769-77. PubMed ID: 1827852
    [No Abstract]   [Full Text] [Related]  

  • 42. [A determination of anti-insulin receptor antibody in serum--a radioreceptor assay excluded the influence of insulin and anti-insulin antibody].
    Satoh K; Kawaguchi R; Yonezawa M; Kubono K; Hikiji K; Ishigami T; Tsukada Y; Takahashi M
    Rinsho Byori; 1990 Mar; 38(3):311-6. PubMed ID: 2190027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor depletion in diabetes mellitus: correction with therapy.
    Eaton RP; Galagan R; Kaufman E; Allen RC; Russell L; Miller F
    Diabetes Care; 1981; 4(2):299-304. PubMed ID: 7011748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cranial pachymeningitis and primary Sjögren's syndrome].
    Abouzaid CH; Kissani N; Essaadouni L
    Rev Neurol (Paris); 2011 Apr; 167(4):348-51. PubMed ID: 21420701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin receptor antibodies causing steroid responsive diabetes mellitus in a patient with myositis.
    Fonseca V; Khokher MA; Dandona P
    Br Med J (Clin Res Ed); 1984 May; 288(6430):1578. PubMed ID: 6426651
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
    Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antireceptor antibodies and insulin resistance. The B type syndrome].
    Lauro R; De Pirro R
    Recenti Prog Med; 1980 Feb; 68(2):189-99. PubMed ID: 6988907
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute leukemia following cyclophosphamide therapy for Sjögren's syndrome.
    Hochberg MC; Shulman LE
    Johns Hopkins Med J; 1978 Jun; 142(6):211-4. PubMed ID: 275517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 52. The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia.
    Flier JS; Bar RS; Muggeo M; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1978 Nov; 47(5):985-95. PubMed ID: 263346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin autoimmune syndrome with insulin-resistant diabetes at the incipient stage prior to hypoglycemic attacks.
    Masuda A; Tsushima T; Shizume K; Shibata K; Kinoshita A; Omori M; Sato Y; Demura H; Ohashi H; Odagiri R
    J Endocrinol Invest; 1986 Dec; 9(6):507-12. PubMed ID: 3571854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia.
    Blevins LS; Gebhart SS
    South Med J; 1996 Jun; 89(6):619-21. PubMed ID: 8638204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin resistance due to receptor antibodies: a complication of progressive systemic sclerosis.
    Weinstein PS; High KA; D'Ercole AJ; Jennette JC
    Arthritis Rheum; 1980 Jan; 23(1):101-5. PubMed ID: 7352930
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.
    el-Reshaid K; al-Mofti S; Stepic NR
    Diabetes Res Clin Pract; 1994 Oct; 25(3):207-10. PubMed ID: 7851276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibodies to the insulin receptor and insulin-resistant diabetes.
    Van Obberghen E; Grunfeld C; Harrison LC; Karlsson A; Muggeo M; Kahn CR
    Horm Res; 1982; 16(5):280-8. PubMed ID: 6757094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunological aspects of insulin therapy of diabetes mellitus and methods of their studies].
    Bykova EV; Bykova AA; Iushkova TA
    Klin Lab Diagn; 1994; (4):29-33. PubMed ID: 7953108
    [No Abstract]   [Full Text] [Related]  

  • 59. Exacerbation of diabetes mellitus by antibodies to exogenous insulin.
    Rendell M; Hamilton RG; Drew HM; Adkinson NF
    Am J Med Sci; 1981; 282(1):18-26. PubMed ID: 7270568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R; Chong AY; Lupsa BC; Lungu AO; Cochran EK; Soos MA; Semple RK; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.